The first report of surgery for gynecological diseases using the hinotori™ surgical robot system

Jpn J Clin Oncol. 2023 Nov 5;53(11):1034-1037. doi: 10.1093/jjco/hyad105.

Abstract

Objective: This study aimed to report the first surgery for gynecological diseases using a new robotic platform, the hinotori™, and validate its feasibility in clinical settings.

Methods: The world's first robot-assisted total hysterectomy for a gynecological ailment was carried out at Kagoshima University Hospital in December 2022 utilizing the hinotori™ surgical robot system. Eleven other patients then underwent comparable procedures. The surgical team was certified to execute the procedure and had undergone official hinotori™ training.

Results: Preoperative diagnoses indicated five cases of endometrial cancer, four cases of uterine myoma and one case each of atypical endometrial hyperplasia, uterine adenosarcoma and high-grade cervical intraepithelial neoplasia. Median age and body mass index were 51 (range: 38-70) years and 26.9 (range: 17.3-33.3) kg/m2, respectively. Median roll-in, cockpit and operation times were 15 (range: 10-18), 161 (range: 110-225) and 214 (range: 154-287) min, respectively. The median blood loss was 22 (range: 7-83) mL and conversion to laparotomy was not allowed. Only one patient had postoperative pelvic region infection. The median length of hospital stay was 6 (range: 4-10) days.

Conclusion: Based on our experience with presented 12 cases, robotic surgery with the hinotori™ is a feasible technique of minimally invasive surgery for gynecological diseases.

Keywords: gynecological diseases; hinotori™; hysterectomy; robotic surgery.

MeSH terms

  • Endometrial Neoplasms* / surgery
  • Female
  • Humans
  • Hysterectomy / methods
  • Laparoscopy* / methods
  • Postoperative Complications
  • Robotic Surgical Procedures* / methods
  • Robotics* / methods
  • Uterine Neoplasms*

Grants and funding